Site Number -1515 — Bellaire, Texas

Site Number -1515 is a clinical research site located in Bellaire, Texas, United States 77401.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Number -1515 has participated in 1 clinical trials.

Therapeutic areas: Thyroid Eye Disease.

Sponsors: Immunovant Sciences GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bellaire

Browse all research sites in Texas · View every site in Bellaire

• First Street Hospital
• The University of Texas
• University of Texas at Houston
• UTHealth McGovern Medical School-Houston and Children's Memorial Hermann Hospital-Houston, 6500 West Loop South, Suite 200-A Texas
• UT Health University of Texas
• University of Texas Physicians
• HD Research- First Surgical Hospital
• First Street Hospital - Research
• University of Texas Health, Houston
• University of Texas Physicians - Bellaire Station
• The University of Texas Health Science Center Houston
• The University of Texas Health Science Center at Houston

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Number -1515?

Site Number -1515 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Number -1515 conducted?

Site Number -1515 has 1 clinical trials on record. Their work covers Thyroid Eye Disease.

Is Site Number -1515 accredited by Crixeo Clinical Trials?

Site Number -1515 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Number -1515?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.